Thomas R Chandler (Thomas Chandler)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Antimicrobial Resistance

Prognostic Factors

Ejection Fraction

Top Venues

Pathogens (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Julio A Ramirez, Stephen Furmanek, Thomas R Chandler, Timothy Wiemken, Paula Peyrani, Forest Arnold, William Mattingly, Ashley M Wilde, Jose Bordon, Rafael Fernandez-Botran, Ruth M Carrico, Rodrigo Cavallazzi, null The University Of Louisville Pneumonia Study Group
Epidemiology of Pneumococcal Pneumonia in Louisville, Kentucky, and Its Estimated Burden of Disease in the United States. Microorganisms 11 (11) (2023)
Jeffrey F Spindel, Stephen Furmanek, Thomas R Chandler, Julio A Ramirez, Rodrigo Cavallazzi
In Patients Hospitalized for Community-Acquired Pneumonia, SARS-CoV-2 Is Associated with Worse Clinical Outcomes When Compared to Influenza. Pathogens (Basel, Switzerland) 12 (4) (2023)
Jeffrey F Spindel, Stephen Furmanek, Thomas R Chandler, Julio A Ramirez, Rodrigo Cavallazzi
In Patients Hospitalized for Community-Acquired Pneumonia, SARS-CoV-2 Is Associated with Worse Clinical Outcomes When Compared to Influenza. Pathogens (Basel, Switzerland) 12 (4) (2023)
Jeffrey F Spindel, Stephen Furmanek, Thomas R Chandler, Julio A Ramirez, Rodrigo Cavallazzi
In Patients Hospitalized for Community-Acquired Pneumonia, SARS-CoV-2 Is Associated with Worse Clinical Outcomes When Compared to Influenza. Pathogens (Basel, Switzerland) 12 (4) (2023)
Jeffrey F Spindel, Stephen Furmanek, Thomas R Chandler, Julio A Ramirez, Rodrigo Cavallazzi
In Patients Hospitalized for Community-Acquired Pneumonia, SARS-CoV-2 Is Associated with Worse Clinical Outcomes When Compared to Influenza. Pathogens (Basel, Switzerland) 12 (4) (2023)
Thomas R Chandler, Stephen Furmanek, Ruth Carrico, Dawn Balcom, Forest Arnold, Julio Ramirez
23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type Streptococcus pneumoniae . Microorganisms 10 (3) (2022)